MedTrace Logo

A Pilot Trial of the Non-invasive H.G.R Glucometer

NCT04658082 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2022-05-23

No results posted yet for this study

Summary

A pilot study evaluating the accuracy of a non-invasive glucose monitor (GWave) with venous glucose measured by core laboratory during a glucose tolerance test (GTT) in patients with type 2 diabetes.

The study is conducted on 5 subjects undergoing a 75gr GTT, with blood glucose measured at baseline and at 8 time points up to 180 minutes post glucose ingestion both by GWave non-invasive glucometer and by core lab glucose measurement.

Conditions

Interventions

DEVICE

H.G.R (GWave) non-invasive glucometer

Glucose tolerance test

Sponsors & Collaborators

  • Prof. Amir Tirosh

    lead OTHER_GOV

Principal Investigators

  • Amir Tirosh, MD PhD · Sheba Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-07
Primary Completion
2020-11-16
Completion
2020-12-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04658082 on ClinicalTrials.gov